0001567619-20-010914.txt : 20200521
0001567619-20-010914.hdr.sgml : 20200521
20200521163958
ACCESSION NUMBER: 0001567619-20-010914
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200519
FILED AS OF DATE: 20200521
DATE AS OF CHANGE: 20200521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kiraly Thomas E
CENTRAL INDEX KEY: 0001623986
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 20902401
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2020-05-19
0
0000722723
HANGER, INC.
HNGR
0001623986
Kiraly Thomas E
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2020-05-19
4
A
0
58030
0
A
284212
D
Common Stock
2020-05-19
4
F
0
22835
17.12
D
261377
D
Stock Options (right to buy)
12.77
2027-05-19
Common Stock
62778
31389
D
Shares received pursuant to the Company's Special Equity Plan as a result of the vesting of PSUs awarded in 2017 due to the achievement of predetermined levels of absolute common stock price compounded annual growth period over the three-year performance period.
Reflects payment of tax liability by withholding shares of stock incident to vesting of performance shares.
Includes (i) unvested restricted shares totaling 17,085 shares of stock from an initial grant of 17,085 shares of restricted stock made on March 9, 2020; (ii) unvested restricted shares and fully vested shares totaling 14,592 shares of stock from an initial grant of 16,185 shares of restricted stock made on March 8, 2019; (iii) unvested restricted shares and fully vested shares totaling 17,294 shares of stock from an initial grant of 19,181 shares of restricted stock made on March 8, 2019; (iv) unvested restricted shares and fully vested shares totaling 14,957 shares of stock from an initial grant of 18,622 shares of restricted stock made on March 9, 2018; (v) unvested restricted shares and fully vested shares totaling 19,486 shares of stock from an initial grant of 26,250 shares of restricted stock, the remainder of which will vest on March 8, 2020 and 2021; [continued in next footnote]
(vi) unvested restricted shares and fully vested shares totaling 18,802 shares of stock from an initial grant of 23,408 shares of restricted stock made on March 8, 2018; (vii) fully vested shares totaling 16,887 shares of stock from an initial grant of 23,844 shares of restricted stock made on March 6, 2015; (viii) unvested restricted shares and fully vested shares totaling 18,558 shares of stock from an initial grant of 25,000 shares of restricted stock made on March 8, 2017; (ix) unvested restricted shares and fully vested shares totaling 3,674 shares of stock from an initial grant of 5,000 shares of restricted stock made on October 11, 2016; (x) unvested restricted shares and fully vested shares totaling 16,886 shares of stock from an initial grant of 25,000 shares of restricted stock April 29, 2016; [continued in next footnote]
(xi) fully vested shares totaling 12,037 shares of stock from an initial grant of 15,896 shares of restricted stock made on March 6, 2015 and (xii) fully vested shares totaling 38,075 shares of stock from an initial grant of 49,660 shares of restricted stock made on October 1, 2014.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Kiraly
2020-05-21